Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability and pharmacokinetic study of dermal application of LEO 29102 in healthy subjects. The study targets Atopic Dermatitis and is sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 29102

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED